Literature DB >> 21422024

Massive thrombi on an implantable cardioverter-defibrillator lead in a patient with the antiphospholipid syndrome.

Waqas Ullah1, John B Chambers, Beverley J Hunt, Christopher Blauth, Christopher A Rinaldi.   

Abstract

A patient with the antiphospholipid syndrome, who was suboptimally anticoagulated, presented with two large thrombi attached to her implantable cardioverter-defibrillator lead. Anticoagulation was unsuccessful so, in view of the risk from embolization, the system was removed surgically and an epicardial system implanted to reduce the risk of future device-related thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422024     DOI: 10.1093/europace/eur070

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  1 in total

1.  Implantable cardioverter defibrillator shock embolizes an atrial septal occluder device in Brugada syndrome.

Authors:  Kothandam Sivakumar; Sreeja Pavithran; Amal Louis; Radhakrishnan Satish
Journal:  Pediatr Cardiol       Date:  2012-07-15       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.